Wednesday, July 13, 2022
Tisch MSRCNY and Dr. Violaine Harris have been featured in an article in Managed Healthcare Executive about the preliminary analysis of results from our FDA-approved stem cell treatment study. The Q&A highlights the impact of our stem cell research, in particular the potential of our biomarker research. The piece also explores Dr. Harris’ broader perspective on the major trends and progress of MS research as a whole, including the connection of MS to the Epstein-Barr virus.
You can read the full article here on the Managed Healthcare Executive website.
Tisch MS Research Center of New York
521 West 57th Street
4th Floor
New York, NY 10019
(646) 557-3900
Support Tisch MS
Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.